Thermo Fisher Ion Proton™ Next-Generation Sequencing System

Overview

The Thermo Fisher Ion Proton™ Next-Generation Sequencing (NGS) System is a benchtop semiconductor-based DNA sequencer engineered for high-throughput, scalable genome-scale analysis. Unlike optical detection platforms, the Ion Proton™ system leverages ion semiconductor technology—measuring hydrogen ion (H⁺) concentration changes generated during nucleotide incorporation in real time. This pH-based detection eliminates the need for fluorescent dyes, optical filters, or lasers, resulting in simplified workflow architecture and reduced per-run consumable complexity. The system delivers whole-exome sequencing (WES) and transcriptome profiling (RNA-Seq) on the Ion PI™ Chip in under 5 hours, and—with the higher-capacity Ion PII™ Chip—enables human whole-genome sequencing (WGS) with >99% coverage uniformity at ~30× depth in a single run completed within 24 hours. Its compact footprint and integrated thermal cycler support deployment in core genomics labs, clinical research facilities, and translational medicine units requiring rapid turnaround without infrastructure-intensive optical alignment or high-power cooling systems.

Key Features

• Semiconductor chip-based sequencing: Direct electronic detection of H⁺ ions released during DNA polymerase-mediated nucleotide incorporation—no optics, no cameras, no labeled nucleotides.
• Scalable throughput architecture: Supports two interchangeable chip formats—Ion PI™ Chip (up to 10 Gb output, ~100 million reads) and Ion PII™ Chip (up to 100 Gb output, ~1 billion reads)—enabling flexible experimental design from targeted panels to human WGS.
• Benchtop form factor: Dimensions of 61 × 56 × 51 cm (W × D × H); operates on standard 110–240 V AC power with passive air cooling—no external chiller or dedicated HVAC required.
• Integrated sample-to-answer workflow: On-instrument templating (Ion OneTouch™ 2 System compatibility), chip loading, sequencing, and base calling (Torrent Suite™ Software v5.12+) performed with minimal manual intervention.
• Run time optimization: Exome sequencing completed in ≤4.5 hours; human WGS (30×) completed in ≤22 hours—including cluster amplification, sequencing, and primary analysis.

Sample Compatibility & Compliance

The Ion Proton™ system accepts double-stranded DNA libraries prepared using Ion AmpliSeq™, Ion TargetSeq™, or other compatible library prep kits validated under Thermo Fisher’s NGS Assay Validation Program. Input requirements range from 10 ng to 100 ng of sheared genomic DNA, FFPE-derived DNA, or RNA-derived cDNA, depending on assay type. All reagents and chips are manufactured under ISO 13485-certified quality systems. The platform supports compliance with GLP and GCP frameworks when deployed with appropriate SOPs and audit-trail-enabled software configurations. While not FDA-cleared as an IVD device, the system is widely used in CLIA-certified laboratories for research-use-only (RUO) applications and LDT development aligned with CAP/CLIA pre-analytical and analytical validation guidelines.

Software & Data Management

Torrent Suite™ Software serves as the embedded primary analysis engine, performing real-time base calling, quality scoring (QV), and BAM file generation. It integrates natively with Ion Reporter™ Software for secondary analysis—including variant calling (TVC algorithm), annotation (using dbSNP, COSMIC, ClinVar), and customizable reporting templates compliant with ACMG variant interpretation standards. Raw data (BAM, VCF, FASTQ) export is supported via SFTP or local USB storage. Audit trail functionality—including user login history, parameter modification logs, and run status timestamps—is enabled by default and configurable to meet 21 CFR Part 11 requirements when paired with enterprise identity management and electronic signature modules. Data retention policies and role-based access control (RBAC) can be enforced through integration with institutional LDAP or Active Directory environments.

Applications

• Whole-exome sequencing for rare disease gene discovery and cancer driver mutation profiling.
• Transcriptome-wide expression quantification and fusion gene detection in solid tumors and hematologic malignancies.
• Targeted resequencing of pharmacogenomic loci (e.g., CYP2D6, DPYD, UGT1A1) in precision oncology workflows.
• Microbiome community profiling via 16S rRNA or ITS amplicon sequencing with multiplexed barcoding.
• Validation of CRISPR-Cas9 editing outcomes through indel frequency quantification and off-target site screening.

FAQ

What chip formats are compatible with the Ion Proton™ system?
The Ion Proton™ system supports the Ion PI™ Chip and Ion PII™ Chip. The Ion PI™ Chip is optimized for exome and transcriptome applications, while the Ion PII™ Chip enables human whole-genome sequencing.
Is the Ion Proton™ system compatible with current Ion Torrent library preparation kits?
Yes—Ion AmpliSeq™, Ion TargetSeq™, and Ion Chef™-compatible library prep kits are fully supported, provided they are version-matched to the installed Torrent Suite™ Software release.
Does the system require specialized facility infrastructure?
No. The Ion Proton™ operates on standard laboratory electrical supply and ambient air cooling. No laser safety enclosure, chilled water loop, or optical darkroom is required.
Can raw sequencing data be exported for third-party analysis?
Yes—FASTQ, BAM, and VCF files are exportable via USB drive or secure network transfer for downstream analysis using open-source tools such as BWA, GATK, or STAR.
Is technical support available globally?
Thermo Fisher provides regional field application scientists and certified service engineers across North America, EMEA, and APAC, with remote diagnostics and on-site maintenance contracts available under extended warranty programs.